Trial Profile
A pilot study of PPX (paclitaxel poliglumex, CT-2103) in women with metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 15 Feb 2008 New trial record.